DIA In Focus Newsletter – Patient Engagement
DIA Making Big Impact in Patient Engagement Research
Effective patient engagement is critical to improving outcomes in the health research continuum. To learn more about how DIA is making an impact or to get involved with DIA’s Patient Engagement Research Initiatives and Think Tanks, visit our website.
Special Collection: Patient Preferences to Inform Decision Making in Medical Product Development
(Therapeutic Innovation & Regulatory Science)
Many preference studies related to treatment choice focus on eliciting patients’ preferences for attributes of treatments that are considered for marketing authorization by regulators. Applications of preference methods to the myriad decisions that sponsors encounter earlier in clinical development have been fewer in number. This Special Collection focuses on applications of patient preference methods to elicit patient input to inform early clinical development decisions.
Patient Engagement Action Plan
Patient involvement in drug development is the key. An interactive DIA Europe 2022 session that had the participation of EFPIA and EPF explored the importance of placing patients and patient experience data at the center. The outcomes of this session were summarized in an article shared at the DIA Global Forum – “Patient Engagement Action Plan: Seven Steps to Move the Needle” ?- and discussions followed in a webinar that included a multistakeholder perspective on the topic. A recent article shared in February on DIA Global Forum consolidated the results and gathered insights from a co-creation exercise held during the webinar with over 100 replies.
Earn CE Credit through DIA’s Patient Engagement Certificate Program
The DIA Patient Engagement Certificate Program provides the foundational knowledge and considerations needed to implement a successful patient engagement program. The program is designed for industry professionals working in, or new to, the medical product development process.
Patient Engagement That Enables Regulatory Decisions:
Co-Creating Next Steps in Patient-Focused Drug Development
Regulators’ expectations of patient involvement in drug development are growing, while new tools are helping to remove practical barriers to working with patients. A multistakeholder group is co-creating a repository of resources that can accelerate progress ahead of the DIA Europe 2023 DIAmond Session on March 24, 2023. The road ahead is clear; only the speed of progress is in doubt.
领英推荐
Free Webinar: From Theory to Practice: Seven Steps for Boosting Patient Engagement
Join speakers from the EMA, EFPIA, EPF, and others in a collaborative discussion on how to increase patient engagement with a practical seven-step action plan.
DIA’s Patient Partners Program
DIA’s Patient Partners Program provides educational experiences to patients and advocates who would not otherwise be supported (e.g., through a project, grant, or professional source) to attend the DIA Global Annual Meeting. In addition, patient partners may participate in unique opportunities to advance understanding of the value of patient engagement in medical product development across the industry.
Join DIA’s Patient Engagement Community
DIA’s Patient Engagement Community (PEC) fosters collaboration between those who represent the patient and those who work to integrate patient needs into the process of medical product development, approval, and commercialization.
Global Annual Meeting Patient Engagement Track
This track addresses meaningful patient engagement in medical product development, from early product development and approval through maintenance phases. It focuses on important questions for all stakeholders, including:
DIA’s Digital Monthly Global Forum is Pleased to Introduce Three New Patient Engagement Editors: ?
Read the current issue to learn more about our Global Forum.